
Sign up to save your podcasts
Or
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
4.7
16081,608 ratings
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
4,135 Listeners
481 Listeners
3,206 Listeners
828 Listeners
2,174 Listeners
1,383 Listeners
3,374 Listeners
807 Listeners
1,499 Listeners
923 Listeners
2,298 Listeners
570 Listeners
378 Listeners
848 Listeners
1,530 Listeners
411 Listeners
237 Listeners